Expanding Parkinson’s disease genetics: novel risk loci, genomic context, causal insights and heritable risk

Mike A. Nalls(National Institutes of Health), Cornelis Blauwendraat(National Institutes of Health), Costanza L. Vallerga(The University of Queensland), Karl Heilbron(23andMe (United States)), Sara Bandrés‐Ciga(National Institutes of Health), Diana Chang, Manuela Tan(University College London), Demis A. Kia(University College London), Alastair J. Noyce(Queen Mary University of London), Angli Xue(The University of Queensland), José Brás(Van Andel Institute), Emily Young(Baylor College of Medicine), Rainer von Coelln(University of Maryland, Baltimore), Javier Simón‐Sánchez(German Center for Neurodegenerative Diseases), Claudia Schulte(German Center for Neurodegenerative Diseases), Manu Sharma(University of Tübingen), Lynne Krohn(Montreal Neurological Institute and Hospital), Lasse Pihlstrøm(Oslo University Hospital), Ari Siitonen(Oulu University Hospital), Hirotaka Iwaki(Michael J. Fox Foundation), Hampton L. Leonard(Data Tecnica International (United States)), Faraz Faghri(University of Illinois Urbana-Champaign), J. Raphael Gibbs(National Institutes of Health), Dena G. Hernandez(National Institutes of Health), Sonja W. Scholz(National Institutes of Health), Juan A. Botía(University College London), María Martínez(Université Toulouse III - Paul Sabatier), Jean‐Christophe Corvol(Centre National de la Recherche Scientifique), Suzanne Lesage(Centre National de la Recherche Scientifique), Joseph Jankovic(Baylor College of Medicine), Lisa M. Shulman(Baylor College of Medicine), Margaret Sutherland(National Institutes of Health), Pentti J. Tienari(University of Helsinki), Kari Majamaa(Oulu University Hospital), Mathias Toft(Oslo University Hospital), Ole A. Andreassen(Oslo University Hospital), Tushar Bangale, Alexis Brice(Centre National de la Recherche Scientifique), Jian Yang(The University of Queensland), Ziv Gan‐Or(Montreal Neurological Institute and Hospital), Thomas Gasser(German Center for Neurodegenerative Diseases), Peter Heutink(German Center for Neurodegenerative Diseases), Joshua Shulman(Baylor College of Medicine), Nicholas Wood(University College London), David A. Hinds(23andMe (United States)), John Hardy(University College London), Huw R. Morris(University College London), Jacob Gratten(The University of Queensland), Peter M. Visscher(The University of Queensland), Robert Graham, Andrew Singleton(National Institutes of Health)
bioRxiv (Cold Spring Harbor Laboratory)
August 9, 2018
Cited by 126Open Access
Full Text

Abstract

Abstract We performed the largest genome-wide association study of PD to date, involving the analysis of 7.8M SNPs in 37.7K cases, 18.6K UK Biobank proxy-cases, and 1.4M controls. We identified 90 independent genome-wide significant signals across 78 loci, including 38 independent risk signals in 37 novel loci. These variants explained 26-36% of the heritable risk of PD. Tests of causality within a Mendelian randomization framework identified putatively causal genes for 70 risk signals. Tissue expression enrichment analysis suggested that signatures of PD loci were heavily brain-enriched, consistent with specific neuronal cell types being implicated from single cell expression data. We found significant genetic correlations with brain volumes, smoking status, and educational attainment. In sum, these data provide the most comprehensive understanding of the genetic architecture of PD to date by revealing many additional PD risk loci, providing a biological context for these risk factors, and demonstrating that a considerable genetic component of this disease remains unidentified.


Related Papers

No related papers found

Powered by citation graph analysis